België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

substipharm ltd. - mitomycine 20 mg - poeder en oplosmiddel voor oplossing voor intravesicaal gebruik - mitomycin

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

substipharm ltd. - mitomycine 20 mg - poeder voor oplossing voor injectie/infusie; poeder voor oplossing voor intravesicaal gebruik - mitomycin

Europese Unie - Nederlands - EMA (European Medicines Agency)

viatris limited - clopidogrelbesilaat - peripheral vascular diseases; stroke; myocardial infarction - antitrombotische middelen - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). het st-segment elevatie acuut myocardinfarct, in combinatie met asa in medisch behandelde patiënten in aanmerking komen voor trombolytische therapie. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. voor meer informatie refereer je naar sectie 5.

Europese Unie - Nederlands - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosuppressiva - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Europese Unie - Nederlands - EMA (European Medicines Agency)

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - geneesmiddelen die worden gebruikt bij diabetes - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 en 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - esomeprazolmagnesium 22,252 mg - eq. esomeprazol 20 mg - maagsapresistente capsule, hard - 20 mg - esomeprazolmagnesium 22.252 mg - esomeprazole

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - esomeprazolmagnesium 44,504 mg - eq. esomeprazol 40 mg - maagsapresistente capsule, hard - 40 mg - esomeprazolmagnesium 44.504 mg - esomeprazole

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - esomeprazolmagnesium 22,252 mg - eq. esomeprazol 20 mg - maagsapresistente capsule, hard - esomeprazole

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - esomeprazolmagnesium 44,504 mg - eq. esomeprazol 40 mg - maagsapresistente capsule, hard - esomeprazole

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - bisoprololfumaraat 2,5 mg - filmomhulde tablet - 2,5 mg - bisoprololfumaraat 2.5 mg - bisoprolol